TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,244,309$19,249,4670.51%
Quantamental Technologies LLC 28,725$444,3760.42%
Psagot Value Holdings Ltd. / (Israel) 45,993$7150.36%
Summit Global Investments 336,324$5,2030.35%
Bridgefront Capital, LLC 23,935$370,2740.26%
Ethic Inc. 461,847$7,144,7750.25%
Covenant Partners, LLC 40,015$619,0330.22%
AlphaQ Advisors LLC 16,606$256,8950.22%
Schechter Investment Advisors, LLC 134,388$2,078,9870.20%
Naviter Wealth, LLC 53,619$829,4860.20%
External links

This page lists TAKEDA PHARMACEUTICAL CO LTD's shareholders in Q3 2023. To view TAKEDA PHARMACEUTICAL CO LTD's shareholder history, click here.